. . . . . . . . . . "scientific article published on 01 December 2019"@en . . . . . . . . . . . . . . . . . . . . . . . . . "4021-4033" . . . . . "23" . . "Michael Spannagl" . "article scientifique publi\u00E9 en 2019"@fr . . . "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03B3RIIA): a new option in HIT?"@en . . . . . "Wolfgang Siess" . "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03B3RIIA): a new option in HIT?"@nl . . . . . "2019-12-01T00:00:00Z"^^ . . . "6963242" . "Rundan Duan" . . . . "wetenschappelijk artikel"@nl . "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03B3RIIA): a new option in HIT?"@nl . "3" . . . . . "Luise Goldmann" . . . . . . . . . . . . . . . "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03B3RIIA): a new option in HIT?"@en . "31809536" . . . . . . . . . "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03B3RIIA): a new option in HIT?"@en . . "Georg Wittmann" . . . "Reinhard Lorenz" . . . . . . . . . . . . . . . . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u n'avientu de 2019"@ast . . . . . "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03B3RIIA): a new option in HIT?"@en . . . . . . . . . . . . . . . . . . "10.1182/BLOODADVANCES.2019000617" . . . . . . . . . . . . "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03B3RIIA): a new option in HIT?"@nl . . . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 1 \u0433\u0440\u0443\u0434\u043D\u044F 2019"@uk . "Thorsten Kragh" . . . .